Systematic assessment of growth factor treatment on biochemical and biomechanical properties of engineered articular cartilage constructs

B. D. Elder, K. A. Athanasiou

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Objective: To determine the effects of bone morphogenetic protein-2 (BMP-2), insulin-like growth factor (IGF-I), and transforming growth factor-β1 (TGF-β1) on the biochemical and biomechanical properties of engineered articular cartilage constructs under serum-free conditions. Methods: A scaffoldless approach for tissue engineering, the self-assembly process, was employed. The study consisted of two phases. In the first phase, the effects of BMP-2, IGF-I, and TGF-β1, at two concentrations and two dosage frequencies each were assessed on construct biochemical and biomechanical properties. In phase II, the effects of growth factor combination treatments were determined. Compressive and tensile mechanical properties, glycosaminoglycan (GAG) and collagen content, histology for GAG and collagen, and immunohistochemistry (IHC) for collagen types I and II were assessed. Results: In phase I, BMP-2 and IGF-I treatment resulted in significant, >1-fold increases in aggregate modulus, accompanied by increases in GAG production. Additionally, TGF-β1 treatment resulted in significant, ∼1-fold increases in both aggregate modulus and tensile modulus, with corresponding increases in GAG and collagen content. In phase II, combined treatment with BMP-2 and IGF-I increased aggregate modulus and GAG content further than either growth factor alone, while TGF-β1 treatment alone remained the only treatment to also enhance tensile properties and collagen content. Discussion: This study determined systematically the effects of multiple growth factor treatments under serum-free conditions, and is the first to demonstrate significant increases in both compressive and tensile biomechanical properties as a result of growth factor treatment. These findings are exciting as coupling growth factor application with the self-assembly process resulted in tissue engineered constructs with functional properties approaching native cartilage values.

Original languageEnglish (US)
Pages (from-to)114-123
Number of pages10
JournalOsteoarthritis and Cartilage
Volume17
Issue number1
DOIs
StatePublished - Jan 2009
Externally publishedYes

Fingerprint

Cartilage
Articular Cartilage
Intercellular Signaling Peptides and Proteins
Glycosaminoglycans
Bone Morphogenetic Protein 2
Insulin-Like Growth Factor I
Transforming Growth Factors
Collagen
Bone
Proteins
Therapeutics
Tensile properties
Self assembly
Collagen Type II
Tissue Engineering
Collagen Type I
Serum
Histology
Insulin
Tissue engineering

Keywords

  • Articular cartilage
  • Extracellular matrix
  • Growth factors
  • Mechanical properties
  • Tissue engineering

ASJC Scopus subject areas

  • Biomedical Engineering
  • Orthopedics and Sports Medicine
  • Rheumatology

Cite this

Systematic assessment of growth factor treatment on biochemical and biomechanical properties of engineered articular cartilage constructs. / Elder, B. D.; Athanasiou, K. A.

In: Osteoarthritis and Cartilage, Vol. 17, No. 1, 01.2009, p. 114-123.

Research output: Contribution to journalArticle

@article{b0f08605dfb343d79e06f82e3352be3d,
title = "Systematic assessment of growth factor treatment on biochemical and biomechanical properties of engineered articular cartilage constructs",
abstract = "Objective: To determine the effects of bone morphogenetic protein-2 (BMP-2), insulin-like growth factor (IGF-I), and transforming growth factor-β1 (TGF-β1) on the biochemical and biomechanical properties of engineered articular cartilage constructs under serum-free conditions. Methods: A scaffoldless approach for tissue engineering, the self-assembly process, was employed. The study consisted of two phases. In the first phase, the effects of BMP-2, IGF-I, and TGF-β1, at two concentrations and two dosage frequencies each were assessed on construct biochemical and biomechanical properties. In phase II, the effects of growth factor combination treatments were determined. Compressive and tensile mechanical properties, glycosaminoglycan (GAG) and collagen content, histology for GAG and collagen, and immunohistochemistry (IHC) for collagen types I and II were assessed. Results: In phase I, BMP-2 and IGF-I treatment resulted in significant, >1-fold increases in aggregate modulus, accompanied by increases in GAG production. Additionally, TGF-β1 treatment resulted in significant, ∼1-fold increases in both aggregate modulus and tensile modulus, with corresponding increases in GAG and collagen content. In phase II, combined treatment with BMP-2 and IGF-I increased aggregate modulus and GAG content further than either growth factor alone, while TGF-β1 treatment alone remained the only treatment to also enhance tensile properties and collagen content. Discussion: This study determined systematically the effects of multiple growth factor treatments under serum-free conditions, and is the first to demonstrate significant increases in both compressive and tensile biomechanical properties as a result of growth factor treatment. These findings are exciting as coupling growth factor application with the self-assembly process resulted in tissue engineered constructs with functional properties approaching native cartilage values.",
keywords = "Articular cartilage, Extracellular matrix, Growth factors, Mechanical properties, Tissue engineering",
author = "Elder, {B. D.} and Athanasiou, {K. A.}",
year = "2009",
month = "1",
doi = "10.1016/j.joca.2008.05.006",
language = "English (US)",
volume = "17",
pages = "114--123",
journal = "Osteoarthritis and Cartilage",
issn = "1063-4584",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Systematic assessment of growth factor treatment on biochemical and biomechanical properties of engineered articular cartilage constructs

AU - Elder, B. D.

AU - Athanasiou, K. A.

PY - 2009/1

Y1 - 2009/1

N2 - Objective: To determine the effects of bone morphogenetic protein-2 (BMP-2), insulin-like growth factor (IGF-I), and transforming growth factor-β1 (TGF-β1) on the biochemical and biomechanical properties of engineered articular cartilage constructs under serum-free conditions. Methods: A scaffoldless approach for tissue engineering, the self-assembly process, was employed. The study consisted of two phases. In the first phase, the effects of BMP-2, IGF-I, and TGF-β1, at two concentrations and two dosage frequencies each were assessed on construct biochemical and biomechanical properties. In phase II, the effects of growth factor combination treatments were determined. Compressive and tensile mechanical properties, glycosaminoglycan (GAG) and collagen content, histology for GAG and collagen, and immunohistochemistry (IHC) for collagen types I and II were assessed. Results: In phase I, BMP-2 and IGF-I treatment resulted in significant, >1-fold increases in aggregate modulus, accompanied by increases in GAG production. Additionally, TGF-β1 treatment resulted in significant, ∼1-fold increases in both aggregate modulus and tensile modulus, with corresponding increases in GAG and collagen content. In phase II, combined treatment with BMP-2 and IGF-I increased aggregate modulus and GAG content further than either growth factor alone, while TGF-β1 treatment alone remained the only treatment to also enhance tensile properties and collagen content. Discussion: This study determined systematically the effects of multiple growth factor treatments under serum-free conditions, and is the first to demonstrate significant increases in both compressive and tensile biomechanical properties as a result of growth factor treatment. These findings are exciting as coupling growth factor application with the self-assembly process resulted in tissue engineered constructs with functional properties approaching native cartilage values.

AB - Objective: To determine the effects of bone morphogenetic protein-2 (BMP-2), insulin-like growth factor (IGF-I), and transforming growth factor-β1 (TGF-β1) on the biochemical and biomechanical properties of engineered articular cartilage constructs under serum-free conditions. Methods: A scaffoldless approach for tissue engineering, the self-assembly process, was employed. The study consisted of two phases. In the first phase, the effects of BMP-2, IGF-I, and TGF-β1, at two concentrations and two dosage frequencies each were assessed on construct biochemical and biomechanical properties. In phase II, the effects of growth factor combination treatments were determined. Compressive and tensile mechanical properties, glycosaminoglycan (GAG) and collagen content, histology for GAG and collagen, and immunohistochemistry (IHC) for collagen types I and II were assessed. Results: In phase I, BMP-2 and IGF-I treatment resulted in significant, >1-fold increases in aggregate modulus, accompanied by increases in GAG production. Additionally, TGF-β1 treatment resulted in significant, ∼1-fold increases in both aggregate modulus and tensile modulus, with corresponding increases in GAG and collagen content. In phase II, combined treatment with BMP-2 and IGF-I increased aggregate modulus and GAG content further than either growth factor alone, while TGF-β1 treatment alone remained the only treatment to also enhance tensile properties and collagen content. Discussion: This study determined systematically the effects of multiple growth factor treatments under serum-free conditions, and is the first to demonstrate significant increases in both compressive and tensile biomechanical properties as a result of growth factor treatment. These findings are exciting as coupling growth factor application with the self-assembly process resulted in tissue engineered constructs with functional properties approaching native cartilage values.

KW - Articular cartilage

KW - Extracellular matrix

KW - Growth factors

KW - Mechanical properties

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=57349126159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57349126159&partnerID=8YFLogxK

U2 - 10.1016/j.joca.2008.05.006

DO - 10.1016/j.joca.2008.05.006

M3 - Article

C2 - 18571441

AN - SCOPUS:57349126159

VL - 17

SP - 114

EP - 123

JO - Osteoarthritis and Cartilage

JF - Osteoarthritis and Cartilage

SN - 1063-4584

IS - 1

ER -